Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
暂无分享，去创建一个
F. Zhan | B. Barlogie | J. Shaughnessy | D. Chao | Jumei Shi | T. Garg | F. van Rhee | S. Yaccoby | Anne van Abbema | A. Rice | Rui Yun | M. Dillon | Xin Li | D. Afar | B. Balasa | S. Szmania | A. Moreno-Bost | Mary K Stone | Bishwa Ganguly